Entrada Therapeutics, Inc. Common Stock

Go to Entrada Therapeutics, Inc. Common Stock Website

$13.88

(%)
Live
Previous Close

$13.88

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$467.4 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosoma...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. HCI Group The Trade: HCI Group Inc (NYSE: HCI) CEO Paresh Patel acquired a total of 1,000 shares an average ...

Related tickers: CRMT, HCI, TRDA.

Read Full Article

ACNB, AMPH and TRDA have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2024.

Related tickers: AMPH, ACNB, TRDA.

Read Full Article
Trending Tickers
CRIS

XNAS

$16.20
(%)
CVNA

XNYS

$116.66
(%)
LASE

XNAS

$2.13
(%)
SQ

XNYS

$71.60
(%)
MLGO

XNAS

$0.00
(%)